Geode Capital Management
CPIX icon

Geode Capital Management’s Cumberland Pharmaceuticals CPIX Stock Holding History

Geode Capital Management’s Portfolio CPIX Stock Details CPIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$371K Buy
114,293
+7,019
+7% +$27K ﹤0.01% 3691
2025
Q4 		$427K Buy
107,274
+5,653
+6% +$16.8K ﹤0.01% 3647
2025
Q3 		$317K Buy
101,621
+1,384
+1% +$4.6K ﹤0.01% 3776
2025
Q2 		$336K Buy
100,237
+1,146
+1% +$5.43K ﹤0.01% 3686
2025
Q1 		$419K Buy
99,091
+24,786
+33% +$103K ﹤0.01% 3611
2024
Q4 		$176K Hold
74,305
– – ﹤0.01% 3941
2024
Q3 		$95.1K Sell
74,305
-14,441
-16% -$20K ﹤0.01% 4117
2024
Q2 		$136K Buy
88,746
+4,224
+5% +$6.64K ﹤0.01% 4041
2024
Q1 		$142K Sell
84,522
-752
-0.9% -$1.5K ﹤0.01% 4042
2023
Q4 		$148K Hold
85,274
– – ﹤0.01% 4047
2023
Q3 		$161K Buy
85,274
+10,691
+14% +$17.9K ﹤0.01% 4064
2023
Q2 		$110K Hold
74,583
– – ﹤0.01% 4300
2023
Q1 		$145K Hold
74,583
– – ﹤0.01% 4188
2022
Q4 		$167K Sell
74,583
-135
-0.2% -$313 ﹤0.01% 4194
2022
Q3 		$180K Hold
74,718
– – ﹤0.01% 4271
2022
Q2 		$155K Buy
74,718
+2,482
+3% +$5.74K ﹤0.01% 4401
2022
Q1 		$203K Buy
72,236
+20,743
+40% +$69K ﹤0.01% 4374
2021
Q4 		$240K Hold
51,493
– – ﹤0.01% 4393
2021
Q3 		$139K Hold
51,493
– – ﹤0.01% 4573
2021
Q2 		$146K Hold
51,493
– – ﹤0.01% 4453
2021
Q1 		$156K Hold
51,493
– – ﹤0.01% 4191
2020
Q4 		$151K Hold
51,493
– – ﹤0.01% 3966
2020
Q3 		$165K Sell
51,493
-624
-1% -$2.05K ﹤0.01% 3774
2020
Q2 		$173K Buy
52,117
+3,507
+7% +$12.8K ﹤0.01% 3699
2020
Q1 		$176K Hold
48,610
– – ﹤0.01% 3587
2019
Q4 		$250K Hold
48,610
– – ﹤0.01% 3726
2019
Q3 		$288K Hold
48,610
– – ﹤0.01% 3658
2019
Q2 		$309K Hold
48,610
– – ﹤0.01% 3640
2019
Q1 		$282K Hold
48,610
– – ﹤0.01% 3635
2018
Q4 		$306K Hold
48,610
– – ﹤0.01% 3546
2018
Q3 		$277K Hold
48,610
– – ﹤0.01% 3651
2018
Q2 		$297K Hold
48,610
– – ﹤0.01% 3606
2018
Q1 		$324K Hold
48,610
– – ﹤0.01% 3543
2017
Q4 		$360K Hold
48,610
– – ﹤0.01% 3478
2017
Q3 		$343K Hold
48,610
– – ﹤0.01% 3487
2017
Q2 		$343K Sell
48,610
-3,482
-7% -$23K ﹤0.01% 3499
2017
Q1 		$361K Buy
52,092
+3,576
+7% +$21.7K ﹤0.01% 3442
2016
Q4 		$266K Buy
48,516
+316
+0.7% +$1.65K ﹤0.01% 3507
2016
Q3 		$241K Buy
48,200
+79
+0.2% +$372 ﹤0.01% 3534
2016
Q2 		$216K Hold
48,121
– – ﹤0.01% 3560
2016
Q1 		$216 Sell
48,121
-79
-0.2% -$376 ﹤0.01% 3610
2015
Q4 		$253K Buy
48,200
+158
+0.3% +$900 ﹤0.01% 3587
2015
Q3 		$277K Buy
48,042
+158
+0.3% +$984 ﹤0.01% 3521
2015
Q2 		$342K Buy
47,884
+79
+0.2% +$549 ﹤0.01% 3365
2015
Q1 		$318K Buy
47,805
+237
+0.5% +$1.48K ﹤0.01% 3396
2014
Q4 		$285K Buy
47,568
+237
+0.5% +$1.22K ﹤0.01% 3432
2014
Q3 		$233K Buy
47,331
+4,239
+10% +$20.5K ﹤0.01% 3514
2014
Q2 		$193K Sell
43,092
-79
-0.2% -$353 ﹤0.01% 3527
2014
Q1 		$194K Buy
43,171
+237
+0.6% +$1.13K ﹤0.01% 3495
2013
Q4 		$219K Buy
42,934
+158
+0.4% +$771 ﹤0.01% 3398
2013
Q3 		$194K Buy
42,776
+158
+0.4% +$787 ﹤0.01% 3319
2013
Q2 		$218K Buy
+42,618
New +$212K ﹤0.01% 3205

Other funds holding CPIX

IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
JGC
J. Goldman & Co New York $3.44B AUM 33.8% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management's CPIX Position: Q1 2026 in Review

Geode Capital Management increased its Cumberland Pharmaceuticals (CPIX) stake by 6.5% in Q1 2026, buying an estimated $27K and bringing the position to 114,293 shares worth $371K. The position accounts for ﹤0.01% of the portfolio, ranked #3691.

Geode Capital Management first reported a position in CPIX in Q2 2013 and has held it in 52 quarters since. The position peaked at $427K in Q4 2025. 29 funds tracked by Wall St. Rank hold CPIX as of Q1 2026.

  • Geode Capital Management held 114,293 shares of Cumberland Pharmaceuticals worth $371K as of Q1 2026.
  • Geode Capital Management bought 7,019 Cumberland Pharmaceuticals shares in Q1 2026, an estimated $27K.
  • Cumberland Pharmaceuticals made up ﹤0.01% of Geode Capital Management's portfolio in Q1 2026, its #3691 holding.
  • Geode Capital Management first reported a position in Cumberland Pharmaceuticals in Q2 2013 and has held it in 52 quarters since.
  • Geode Capital Management's Cumberland Pharmaceuticals position peaked at $427K in Q4 2025.
  • 29 funds tracked by Wall St. Rank held Cumberland Pharmaceuticals as of Q1 2026.

Based on Geode Capital Management's 13F filing for Q1 2026, filed 15 May 2026.